Comparison of the outcome between cycles stimulated with r-FSH or clomiphene citrate in patients undergoing intrauterine insemination: Analysis of 130 cycles

Volume: 52 Number: 1 March 1, 2013
  • Hacıvelioğlu S
  • Gencer M
  • Çakır Güngör A N
  • Uysal A
  • Coşar E
Ege Journal of Medicine Cover
Ege Journal of Medicine
PDF Download
EN TR

Comparison of the outcome between cycles stimulated with r-FSH or clomiphene citrate in patients undergoing intrauterine insemination: Analysis of 130 cycles

Abstract

Aim: The best ovulation induction (OI) protocol in intrauterine insemination (IUI) cycles is still unknown. The aim of this retrospective study was to investigate the effects of two different OI protocols, r-FSH and clomiphene citrate (CC), on the pregnancy rates in IUI cycles. Materials and Methods: One hundred and thirty cycles were retrospectively evaluated in patients who underwent IUI with fresh sperm from their husbands. The study included two treatment arms; the groups consisted of 35 treatment cycles with r-FSH + IUI and 95 treatment cycles with CC + IUI, respectively. The two groups were compared in terms of various clinical and laboratory parameters. Results: The pregnancy rates in r-FSH and CC groups were 17.1% and 10.5%, respectively, and no statistical difference was found (p=0.368). The endometrial thickness (ET) on the day of hCG trigger was less in the CC group (p

Keywords

Details

Primary Language

Turkish

Subjects

-

Journal Section

-

Authors

Hacıvelioğlu S

Gencer M

Çakır Güngör A N

Uysal A

Coşar E

Publication Date

March 1, 2013

Submission Date

March 1, 2013

Acceptance Date

-

Published in Issue

Year 2013 Volume: 52 Number: 1

IZ

https://izlik.org/JA53XA25XF

Cite

RIS / Bibtex
Vancouver
1.Hacıvelioğlu S, Gencer M, Çakır Güngör A N, Uysal A, Coşar E. İntraüterin inseminasyon uygulanan hastalarda r-FSH ve klomifen sitrat ile ovülasyon indüksiyon sonuçlarının karşılaştırılması: 130 siklusun analizi. EJM [Internet]. 2013 Mar. 1;52(1):37-42. Available from: https://izlik.org/JA53XA25XF

Ege Journal of Medicine enables the sharing of articles according to the Attribution-Non-Commercial-Share Alike 4.0 International (CC BY-NC-SA 4.0) license.